Delivery Order SPE2DR25D1103-SPE2DR26FE938
- Not listed
- The Defense Logistics Agency awarded a $22,469.61 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 11, 2025, and represents a small-value pharmaceutical delivery. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $31,949.98 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,551.02 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) under a firm fixed-price contract. The award was made on December 30, 2025, with an ultimate completion date of December 31, 2025, with performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a Delivery Order valued at $8,406.33 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging). This competitively awarded, firm fixed-price contract was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $7,302.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 5, 2025, with completion scheduled for December 8, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency has awarded a delivery order valued at $8,161.26 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units). The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. The award was made on November 4, 2025, with an ultimate completion date of November 5, 2025, and the place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,186.80 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count) under a firm fixed-price contract. The award was issued on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,235.76 for NURTEC ODT 75 MG tablets (8-count) on December 2, 2025, with completion scheduled for December 3, 2025. This competitive, non-set-aside award reflects a firm fixed price contract for pharmaceutical delivery to support federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $6,218.91 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 15, 2025, with completion scheduled for December 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger prime vehicle with DLA. The pharmaceutical product will be performed and supplied from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,240.94 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on December 12, 2025, with completion targeted for December 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken,...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE938Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,655.81 to Amerisourcebergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count) on January 27, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order will be completed by January 28, 2026. This delivery order operates under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Amerisourcebergen, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, providing an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The parent company Cencora also maintains a separate $999,999,999.00 IDC with DLA through December 31, 2031, demonstrating the company's substantial role in supporting Department of Defense medical supply chain operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/26/26 |